Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients
- PMID: 19554246
- PMCID: PMC4501027
- DOI: 10.1007/s00198-009-0988-9
Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients
Abstract
We evaluated the associations between dual energy X-ray absorptiometry (DXA) and histologically determined cancellous and cortical bone volume by controlling for vascular calcifications and demographic variables in hemodialysis (HD) patients. Femoral bone mineral density (f-BMD) was associated with cortical porosity.
Introduction: Assessment of bone mass in chronic kidney disease patients is of clinical importance because of the association between low bone volume, fractures, and vascular calcifications. DXA is used for noninvasive assessment of bone mass whereby vertebral results reflect mainly cancellous bone and femoral results reflect mainly cortical bone. Bone histology allows direct measurements of cancellous and cortical bone volume. The present study evaluates the association between DXA and histologically determined cancellous and cortical bone volumes in HD patients.
Methods: In 38 HD patients, DXA was performed for assessment of bone mass, anterior iliac crest bone biopsies for bone volume, and multislice computed tomography for vascular calcifications.
Results: While lumbar bone mineral density (l-BMD) by DXA was not associated with histologically measured cancellous bone volume, coronary Agatson score showed a borderline statistically significant association (P = 0.055). When controlled for age and dialysis duration, f-BMD by DXA was associated with cortical porosity determined by histology (P = 0.005).
Conclusions: The usefulness of l-BMD for predicting bone volume is limited most probably because of interference by soft tissue calcifications. In contrast, f-BMD shows significant association with cortical porosity.
Conflict of interest statement
Figures
Similar articles
-
Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture.PLoS One. 2017 Feb 15;12(2):e0171873. doi: 10.1371/journal.pone.0171873. eCollection 2017. PLoS One. 2017. PMID: 28199411 Free PMC article.
-
The contribution of cortical and cancellous bone to dual-energy X-ray absorptiometry measurements in the female proximal femur.Osteoporos Int. 2001;12(3):192-8. doi: 10.1007/s001980170129. Osteoporos Int. 2001. PMID: 11315237
-
Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.Artif Organs. 2009 Oct;33(10):844-54. doi: 10.1111/j.1525-1594.2009.00814.x. Epub 2009 Jul 22. Artif Organs. 2009. PMID: 19681840
-
Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.J Clin Densitom. 2017 Oct-Dec;20(4):490-497. doi: 10.1016/j.jocd.2016.11.002. Epub 2016 Dec 27. J Clin Densitom. 2017. PMID: 28039046
-
Diagnosis of low bone mass in CKD-5D patients.Clin Nephrol. 2016 Feb;85(2):77-83. doi: 10.5414/CN108708. Clin Nephrol. 2016. PMID: 26587778 Free PMC article.
Cited by
-
A microRNA Approach to Discriminate Cortical Low Bone Turnover in Renal Osteodystrophy.JBMR Plus. 2020 Mar 25;4(5):e10353. doi: 10.1002/jbm4.10353. eCollection 2020 May. JBMR Plus. 2020. PMID: 32490328 Free PMC article.
-
Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients.PLoS One. 2017 Jul 7;12(7):e0179868. doi: 10.1371/journal.pone.0179868. eCollection 2017. PLoS One. 2017. PMID: 28686736 Free PMC article. Clinical Trial.
-
The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.Clin Nephrol. 2010 Dec;74(6):423-32. Clin Nephrol. 2010. PMID: 21084045 Free PMC article.
-
Association between bone mineral density at different anatomical sites and both mortality and fracture risk in patients receiving renal replacement therapy: a longitudinal study.Clin Kidney J. 2022 Jan 31;15(6):1188-1195. doi: 10.1093/ckj/sfac034. eCollection 2022 Jun. Clin Kidney J. 2022. PMID: 35664286 Free PMC article.
-
Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation.Kidney Int Suppl (2011). 2011 Sep;1(4):122-129. doi: 10.1038/kisup.2011.28. Kidney Int Suppl (2011). 2011. PMID: 25018911 Free PMC article. Review.
References
-
- Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000;58:396–399. - PubMed
-
- Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, Mason N, Prutz KG, Young EW, Pisoni RL. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int. 2006;70:1358–1366. - PubMed
-
- Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab. 2004;89:4246–4253. - PubMed
-
- Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000;36:1115–1121. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical